| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | RTI SURGICAL HOLDINGS INC COM | 1,860,000 | 7,440,000 | 0.62% | ||
| 52 | COOPER COS INC | 47,600 | 7,329,000 | 0.61% | ||
| 53 | EPIZYME INC COM | 589,000 | 7,139,000 | 0.60% | ||
| 54 | RETROPHIN INC | 521,400 | 7,122,000 | 0.60% | ||
| 55 | SERES THERAPEUTICS INC | 262,000 | 6,959,000 | 0.58% | ||
| 56 | EDWARDS LIFESCIENCES CORP | 76,000 | 6,704,000 | 0.56% | ||
| 57 | VERTEX PHARMACEUTICALS INC | 83,900 | 6,669,000 | 0.56% | ||
| 58 | ALKERMES PLC | 194,500 | 6,650,000 | 0.56% | ||
| 59 | CORVUS PHARMACEUTICALS INC COM | 456,887 | 6,625,000 | 0.56% | ||
| 60 | BEIGENE LTD | 225,000 | 6,595,000 | 0.55% | ||
| 61 | Intersect ENT Inc | 340,000 | 6,460,000 | 0.54% | ||
| 62 | ATHENA HEALTH INC. | 45,750 | 6,349,000 | 0.53% | ||
| 63 | ADAPTIMMUNE THERAPEUTICS PLC | 765,001 | 6,219,000 | 0.52% | ||
| 64 | NOVADAQ TECHNOLOGIES INC | 555,000 | 6,155,000 | 0.52% | ||
| 65 | Heartware International, Inc. | 193,000 | 6,064,000 | 0.51% | ||
| 66 | DERMIRA INC COM | 290,000 | 5,997,000 | 0.50% | ||
| 67 | COHERUS BIOSCIENCES INC COM | 282,000 | 5,987,000 | 0.50% | ||
| 68 | REGENERON PHARMACEUTICALS | 16,500 | 5,947,000 | 0.50% | ||
| 69 | FIVE PRIME THERAPEUTICS INC | 144,500 | 5,871,000 | 0.49% | ||
| 70 | INSYS THERAPEUTICS INC NEW COM NEW | 365,500 | 5,844,000 | 0.49% | ||
| 71 | INSMED INC | 450,000 | 5,702,000 | 0.48% | ||
| 72 | ENVISION HEALTHCARE HLDGS INC | 266,000 | 5,426,000 | 0.45% | ||
| 73 | CHINA CORD BLOOD CORP | 880,000 | 5,342,000 | 0.45% | ||
| 74 | ADURO BIOTECH INC | 415,000 | 5,316,000 | 0.45% | ||
| 75 | INTRA-CELLULAR THERAPIES INC | 187,500 | 5,213,000 | 0.44% | ||
| 76 | AMICUS THERAPEUTICS INC COM | 613,500 | 5,184,000 | 0.43% | ||
| 77 | Ascendis Pharma | 270,000 | 5,009,000 | 0.42% | ||
| 78 | XENOPORT INC | 1,100,000 | 4,961,000 | 0.42% | ||
| 79 | TANDEM DIABETES CARE INC COM | 562,500 | 4,899,000 | 0.41% | ||
| 80 | CARDIOME PHARMA CORP | 1,190,000 | 4,867,000 | 0.41% | ||
| 81 | ALLERGAN PLC | 5,000 | 4,585,000 | 0.38% | ||
| 82 | COMPUGEN LTD | 820,000 | 4,576,000 | 0.38% | ||
| 83 | PROTEOSTASIS THERAPEUTICS IN COM | 470,000 | 4,531,000 | 0.38% | ||
| 84 | CHIASMA INC | 492,500 | 4,511,000 | 0.38% | ||
| 85 | NOVAVAX INC COM | 852,500 | 4,399,000 | 0.37% | ||
| 86 | FIBROGEN INC | 204,000 | 4,343,000 | 0.36% | ||
| 87 | MACROGENICS INC | 225,000 | 4,219,000 | 0.35% | ||
| 88 | AIMMUNE THERAPEUTICS INC COM | 293,000 | 3,973,000 | 0.33% | ||
| 89 | AVEXIS INC COM | 142,758 | 3,889,000 | 0.33% | ||
| 90 | PERRIGO CO PLC | 30,000 | 3,838,000 | 0.32% | ||
| 91 | GENOCEA BIOSCIENCES INC | 480,000 | 3,715,000 | 0.31% | ||
| 92 | KITE PHARMA INCORPORATED | 80,000 | 3,673,000 | 0.31% | ||
| 93 | Otonomy Inc | 240,000 | 3,581,000 | 0.30% | ||
| 94 | PORTOLA PHARMACEUTICALS INC | 175,000 | 3,570,000 | 0.30% | ||
| 95 | ADR - Nabriva Therapeutics AG- Usd | 380,000 | 3,405,000 | 0.29% | ||
| 96 | MEDICINES CO SR GLBL CV NT 22 | 3,000,000 | 3,405,000 | 0.29% | PRN | |
| 97 | PARATEK PHARMACEUTICALS INC | 223,000 | 3,383,000 | 0.28% | ||
| 98 | CIDARA THERAPEUTICS INC | 250,000 | 3,175,000 | 0.27% | ||
| 99 | DYNAVAX TECHNOLOGIES CORP | 165,000 | 3,175,000 | 0.27% | ||
| 100 | NOVOCURE LTD | 214,316 | 3,103,000 | 0.26% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-003409, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
